| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.065 | 0.2 |
| mRNA | QL-X-138 | GDSC1000 | pan-cancer | AAC | 0.038 | 0.2 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.2 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | Gefitinib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | piperlongumine | GDSC1000 | pan-cancer | AAC | 0.04 | 0.2 |
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.35 | 0.2 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |